全文获取类型
收费全文 | 22012篇 |
免费 | 1877篇 |
国内免费 | 47篇 |
专业分类
耳鼻咽喉 | 128篇 |
儿科学 | 585篇 |
妇产科学 | 329篇 |
基础医学 | 2884篇 |
口腔科学 | 389篇 |
临床医学 | 2372篇 |
内科学 | 4343篇 |
皮肤病学 | 223篇 |
神经病学 | 2018篇 |
特种医学 | 846篇 |
外科学 | 3483篇 |
综合类 | 341篇 |
一般理论 | 57篇 |
预防医学 | 2517篇 |
眼科学 | 312篇 |
药学 | 1524篇 |
中国医学 | 71篇 |
肿瘤学 | 1514篇 |
出版年
2023年 | 179篇 |
2022年 | 261篇 |
2021年 | 599篇 |
2020年 | 408篇 |
2019年 | 566篇 |
2018年 | 642篇 |
2017年 | 498篇 |
2016年 | 535篇 |
2015年 | 593篇 |
2014年 | 776篇 |
2013年 | 1094篇 |
2012年 | 1679篇 |
2011年 | 1626篇 |
2010年 | 969篇 |
2009年 | 835篇 |
2008年 | 1465篇 |
2007年 | 1372篇 |
2006年 | 1288篇 |
2005年 | 1308篇 |
2004年 | 1191篇 |
2003年 | 1066篇 |
2002年 | 924篇 |
2001年 | 351篇 |
2000年 | 326篇 |
1999年 | 281篇 |
1998年 | 202篇 |
1997年 | 167篇 |
1996年 | 170篇 |
1995年 | 126篇 |
1994年 | 139篇 |
1993年 | 118篇 |
1992年 | 164篇 |
1991年 | 178篇 |
1990年 | 128篇 |
1989年 | 124篇 |
1988年 | 141篇 |
1987年 | 161篇 |
1986年 | 139篇 |
1985年 | 122篇 |
1984年 | 90篇 |
1983年 | 73篇 |
1982年 | 62篇 |
1981年 | 54篇 |
1980年 | 59篇 |
1979年 | 82篇 |
1978年 | 60篇 |
1977年 | 64篇 |
1975年 | 45篇 |
1974年 | 54篇 |
1972年 | 44篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Thomas Asendorf Robin Henderson Heinz Schmidli Tim Friede 《Statistics in medicine》2019,38(9):1503-1528
In some diseases, such as multiple sclerosis, lesion counts obtained from magnetic resonance imaging (MRI) are used as markers of disease progression. This leads to longitudinal, and typically overdispersed, count data outcomes in clinical trials. Models for such data invariably include a number of nuisance parameters, which can be difficult to specify at the planning stage, leading to considerable uncertainty in sample size specification. Consequently, blinded sample size re-estimation procedures are used, allowing for an adjustment of the sample size within an ongoing trial by estimating relevant nuisance parameters at an interim point, without compromising trial integrity. To date, the methods available for re-estimation have required an assumption that the mean count is time-constant within patients. We propose a new modeling approach that maintains the advantages of established procedures but allows for general underlying and treatment-specific time trends in the mean response. A simulation study is conducted to assess the effectiveness of blinded sample size re-estimation methods over fixed designs. Sample sizes attained through blinded sample size re-estimation procedures are shown to maintain the desired study power without inflating the Type I error rate and the procedure is demonstrated on MRI data from a recent study in multiple sclerosis. 相似文献
5.
6.
7.
Regina K. Rowe David M. Pyle J. David Farrar Michelle A. Gill 《European journal of immunology》2020,50(10):1550-1559
Rhinovirus (RV) infections are linked to the development and exacerbation of allergic diseases including allergic asthma. IgE, another contributor to atopic disease pathogenesis, has been shown to regulate DC antiviral functions and influence T cell priming by monocytes. We previously demonstrated that IgE-mediated stimulation of monocytes alters multiple cellular functions including cytokine secretion, phagocytosis, and influenza-induced Th1 development. In this study, we investigate the effects of IgE-mediated stimulation on monocyte-driven, RV-induced T cell development utilizing primary human monocyte-T cell co-cultures. We demonstrate that IgE crosslinking of RV-exposed monocytes enhances monocyte-driven Th2 differentiation. This increase in RV-induced Th2 development was regulated by IgE-mediated inhibition of virus-induced type I IFN and induction of IL-10. These findings suggest an additional mechanism by which two clinically significant risk factors for allergic disease exacerbations—IgE-mediated stimulation and rhinovirus infection—may synergistically promote Th2 differentiation and allergic inflammation. 相似文献
8.
9.
10.